P17-17. Newborn mice vaccination with rBCG:HIVA + MVA:HIVA enhances HIV-1-specific immune responses. Influence of age and immunization routes

N. Saubi; E. Im; R. Fernandez-Lloris; O. Gil; P. Cardona; J. Gatell; T. Hanke; J. Joseph

doi:10.1186/1742-4690-6-S3-P299

P17-17. Newborn mice vaccination with rBCG:HIVA + MVA:HIVA enhances HIV-1-specific immune responses. Influence of age and immunization routes

N. Saubi, E. Im, R. Fernandez-Lloris, O. Gil, P. Cardona, J. Gatell, T. Hanke, J. Joseph^*

^*Corresponding author for this work

Department of Genetics and Microbiology

Research output: Contribution to journal › Article › Research › peer-review

Abstract

It has been demonstrated by several groups that the use of rBCG expressing HIV immunogens is a good priming vector for vaccinia based HIV vaccines, mainly in the prevention of mother-to-child HIV transmission. Our group has shown in Balb/C mice that rBCG:HIVA can both prime novel and boost preexisting HIV-1 specific cellular immune responses. In this study we have evaluated the HIV specific cellular immune responses induced after newborn and adult mice immunization using different routes with rBCG:HIVA prime and MVA:HIVA boost

Original language	English
Article number	1742
Pages (from-to)	P299
Number of pages	1
Journal	Retrovirology
Volume	6
Issue number	SUPPL. 3
DOIs	https://doi.org/10.1186/1742-4690-6-S3-P299
Publication status	Published - 22 Oct 2009

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1186/1742-4690-6-S3-P299

Cite this

@article{d343efead3854a769a09dcca17f23d79,

title = "P17-17. Newborn mice vaccination with rBCG:HIVA + MVA:HIVA enhances HIV-1-specific immune responses. Influence of age and immunization routes",

abstract = "It has been demonstrated by several groups that the use of rBCG expressing HIV immunogens is a good priming vector for vaccinia based HIV vaccines, mainly in the prevention of mother-to-child HIV transmission. Our group has shown in Balb/C mice that rBCG:HIVA can both prime novel and boost preexisting HIV-1 specific cellular immune responses. In this study we have evaluated the HIV specific cellular immune responses induced after newborn and adult mice immunization using different routes with rBCG:HIVA prime and MVA:HIVA boost",

author = "N. Saubi and E. Im and R. Fernandez-Lloris and O. Gil and P. Cardona and J. Gatell and T. Hanke and J. Joseph",

year = "2009",

month = oct,

day = "22",

doi = "10.1186/1742-4690-6-S3-P299",

language = "English",

volume = "6",

pages = "P299",

journal = "Retrovirology",

issn = "1742-4690",

publisher = "BioMed Central Ltd.",

number = "SUPPL. 3",

}

TY - JOUR

T1 - P17-17. Newborn mice vaccination with rBCG:HIVA + MVA:HIVA enhances HIV-1-specific immune responses. Influence of age and immunization routes

AU - Saubi, N.

AU - Im, E.

AU - Fernandez-Lloris, R.

AU - Gil, O.

AU - Cardona, P.

AU - Gatell, J.

AU - Hanke, T.

AU - Joseph, J.

PY - 2009/10/22

Y1 - 2009/10/22

N2 - It has been demonstrated by several groups that the use of rBCG expressing HIV immunogens is a good priming vector for vaccinia based HIV vaccines, mainly in the prevention of mother-to-child HIV transmission. Our group has shown in Balb/C mice that rBCG:HIVA can both prime novel and boost preexisting HIV-1 specific cellular immune responses. In this study we have evaluated the HIV specific cellular immune responses induced after newborn and adult mice immunization using different routes with rBCG:HIVA prime and MVA:HIVA boost

AB - It has been demonstrated by several groups that the use of rBCG expressing HIV immunogens is a good priming vector for vaccinia based HIV vaccines, mainly in the prevention of mother-to-child HIV transmission. Our group has shown in Balb/C mice that rBCG:HIVA can both prime novel and boost preexisting HIV-1 specific cellular immune responses. In this study we have evaluated the HIV specific cellular immune responses induced after newborn and adult mice immunization using different routes with rBCG:HIVA prime and MVA:HIVA boost

UR - https://www.scopus.com/pages/publications/70449709268

U2 - 10.1186/1742-4690-6-S3-P299

DO - 10.1186/1742-4690-6-S3-P299

M3 - Article

AN - SCOPUS:70449709268

SN - 1742-4690

VL - 6

SP - P299

JO - Retrovirology

JF - Retrovirology

IS - SUPPL. 3

M1 - 1742

ER -

P17-17. Newborn mice vaccination with rBCG:HIVA + MVA:HIVA enhances HIV-1-specific immune responses. Influence of age and immunization routes

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this